click tracking
Swiss Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 201 - 220 out of 301 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16 »

FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders

Read more ››
By: Nasdaq / GlobenewsWire - 30 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App

HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21(st) Diabetes and Cardiovascular Risk Factors - East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing the accuracy of blood glucose monitoring systems (BGMSs) in the low blood glucose range (LBGR)... Read more ››

By: PR Newswire Association LLC. - 30 Sep 2019
Related companies:  Ascensia Diabetes Care Netherlands BV | Ascensia Diabetes Care Holdings AG

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

Read more ››
By: Nasdaq / GlobenewsWire - 28 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

Read more ››
By: Nasdaq / GlobenewsWire - 27 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer

Read more ››
By: Nasdaq / GlobenewsWire - 27 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

ObsEva SA to Participate in Cantor Global Healthcare Conference October 2-4, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 27 Sep 2019
Related companies:  ObsEva SA

Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc.

SUZHOU, China, Sept. 26, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, announced today an expansion of its integrated clinical trials supply and distribution services network, in Suzhou, China, as well as a collaboration with Frontier Biotechnologies Inc.... Read more ››

By: PR Newswire Association LLC. - 26 Sep 2019

ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2019 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON SEPTEMBER 30, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 25 Sep 2019
Related companies:  Addex Therapeutics S.A.

Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)

Read more ››
By: Nasdaq / GlobenewsWire - 25 Sep 2019
Related companies:  Sequana Medical NV | Sequana Medical NV

Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 25 Sep 2019
Related companies:  Sequana Medical NV | Sequana Medical NV

Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China

LUGANO, Switzerland and BEIJING, Sept. 25, 2019 /PRNewswire/ -- Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Mundipharma China Pharmaceutical, the market leader in pain management, today jointly announce that the National Medical Products Administration... Read more ››

By: PR Newswire Association LLC. - 25 Sep 2019
Related companies:  Helsinn Healthcare SA | Helsinn Advanced Synthesis SA | Helsinn Healthcare SA

Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares

Read more ››
By: Nasdaq / GlobenewsWire - 24 Sep 2019
Related companies:  Addex Therapeutics S.A.

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 23 Sep 2019

Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress

Read more ››
By: Nasdaq / GlobenewsWire - 23 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis  

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2019

Rybelsus® (semaglutide tablets), the first GLP-1 in a tablet approved in the US

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2019

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Genkyotex Announces First Half 2019 Results

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Genkyotex S.A.

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

BASEL, Switzerland, Sept. 19, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Novartis International AG | Novartis Venture Fund | Novartis Pharma Schweiz AG | Novartis Pharma AG

Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16 »

Looking for companies outside of Switzerland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • January 2020
    • Basel: R&D Data Intel Leaders Forum
    • Nice: AgeingFIT
  • February 2020
    • Zürich: Swiss Nordic Bio 2020
See Events »
Add an Event »

Latest company news

Addex Starts Trading American Depositary Shares on Nasdaq Under Ticker ADXN
29 Jan 2020 (GlobenewsWire)

Smart Decision Announces Reaching and Exceeding its Goal of Adding Additional CBD Brands Joining the CBDSmartDecision.com Platform
28 Jan 2020 (GlobenewsWire)

Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
28 Jan 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Swiss Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com